We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.58B
AUM Growth
+$210M
Cap. Flow
+$71.1M
Cap. Flow %
4.5%
Top 10 Hldgs %
18.14%
Holding
221
New
32
Increased
92
Reduced
20
Closed
27

Top Buys

Rank Stock Value
1
ASND icon
Ascendis Pharma A/S
ASND
+$12.6M
2
PIII icon
P3 Health Partners
PIII
+$10.1M
3
MRVI icon
Maravai LifeSciences
MRVI
+$9.23M
4
NARI
Inari Medical, Inc. Common Stock
NARI
+$8.99M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$8.85M

Top Sells

Rank Stock Value
1
AMRS
Amyris Inc.
AMRS
+$13M
2
DMTK
DermTech, Inc. Common Stock
DMTK
+$12.9M
3
OSH
Oak Street Health, Inc.
OSH
+$11.8M
4
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$9.93M
5
DNA icon
Ginkgo Bioworks
DNA
+$8.89M

Sector Composition

Rank Sector Weight
1 Healthcare 30.22%
2 Technology 18.11%
3 Financials 10.26%
4 Industrials 8.95%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LVTX
126
DELISTED
LAVA Therapeutics
LVTX
$2.88M 0.18%
523,920
-5,033
-1% -$33K
AAPL icon
127
Apple
AAPL
$4.57T
$2.88M 0.18%
+16,215
New +$2.56M
MTCH icon
128
Match Group
MTCH
$8.55B
$2.82M 0.18%
21,329
-5,574
-21% -$807K
MTDR icon
129
Matador Resources
MTDR
$6.09B
$2.63M 0.17%
+71,216
New +$2.91M
EL icon
130
Estee Lauder
EL
$32B
$2.57M 0.16%
6,943
– –
PK icon
131
Park Hotels & Resorts
PK
$2.97B
$2.47M 0.16%
+130,752
New +$2.46M
MRVL icon
132
Marvell Technology
MRVL
$196B
$2.4M 0.15%
+27,398
New +$2.05M
MP icon
133
MP Materials
MP
$9.1B
$2.28M 0.14%
+50,184
New +$1.98M
IWM icon
134
iShares Russell 2000 ETF
IWM
$83B
$2.07M 0.13%
+9,314
New +$2.1M
DALS
135
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
$1.96M 0.12%
200,000
– –
MDB icon
136
MongoDB
MDB
$32.1B
$1.92M 0.12%
+3,625
New +$1.86M
ROKU icon
137
Roku
ROKU
$22.7B
$1.91M 0.12%
8,373
+2,329
+39% +$628K
CCJ icon
138
Cameco
CCJ
$42.4B
$1.9M 0.12%
+87,167
New +$2.11M
GNRC icon
139
Generac Holdings
GNRC
$12.5B
$1.76M 0.11%
4,996
– –
PYPL icon
140
PayPal
PYPL
$50.5B
$1.74M 0.11%
9,201
-4,020
-30% -$870K
SNTI icon
141
Senti Biosciences Holdings
SNTI
$11M
$1.73M 0.11%
17,500
– –
SWCH
142
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$1.69M 0.11%
59,124
+28,666
+94% +$749K
SNAP icon
143
Snap
SNAP
$9.01B
$1.57M 0.1%
33,400
-8,182
-20% -$460K
ONON icon
144
On Holding
ONON
$12.5B
$1.23M 0.08%
32,645
+11,690
+56% +$429K
CFLT
145
DELISTED
Confluent
CFLT
$1.12M 0.07%
+14,639
New +$1.06M
EPAM icon
146
EPAM Systems
EPAM
$5.03B
$1.1M 0.07%
1,645
– –
CDLX icon
147
Cardlytics
CDLX
$21.5M
$1.09M 0.07%
1,657
-2,402
-59% -$1.84M
ZBRA icon
148
Zebra Technologies
ZBRA
$17.8B
$1.05M 0.07%
1,771
– –
MAT icon
149
Mattel
MAT
$4.23B
$954K 0.06%
44,255
+15,032
+51% +$315K
CMG icon
150
Chipotle Mexican Grill
CMG
$41.5B
$941K 0.06%
+26,900
New +$947K
4 5
6
7 8

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Nicholas Investment Partners held 221 positions worth $1.58B, up 15% from $1.37B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners deployed $71.1M of net new capital in Q4 2021, opening 32 new positions and adding to 92 existing holdings. Its largest new stake was P3 Health Partners: 21,075 shares worth $7.42M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 36% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Ginkgo Bioworks, an estimated $8.89M trimmed.

  • Nicholas Investment Partners's largest Q4 2021 buy was P3 Health Partners: 21,075 shares worth $7.42M.
  • Nicholas Investment Partners added most to Ascendis Pharma A/S in Q4 2021, an estimated $12.6M increase.
  • Nicholas Investment Partners's biggest Q4 2021 reduction was Ginkgo Bioworks, cutting an estimated $8.89M.
  • Nicholas Investment Partners fully exited Amyris Inc. in Q4 2021, selling an estimated $13M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.58B portfolio in Q4 2021.
  • Nicholas Investment Partners opened 32 new positions and closed 27 in Q4 2021.
  • Nicholas Investment Partners's portfolio value rose 15% quarter-over-quarter to $1.58B.

Based on Nicholas Investment Partners's 13F filing for Q4 2021, filed 14 Feb 2022.